Table 3 Baseline characteristics associated with control of NCD

Age category

 < 40

16 (19.8)

 40–50

38 (46.9)

 > 50

27 (33.3)

0.974

Sex

 Male

25 (30.9)

 Female

56 (69.1)

0.072

NCD

 DM only

2 (2.5)

 HTN only

74 (91.4)

 HTN and DM

5 (6.2)

0.430

BMI

 < 18.5

0 (0)

 18.5–< 25

9 (20.9)

 25–< 30

9 (20.9

0.654

 > 30

25 (58.1)

WHO stage

 0

25 (30.9)

 1

21 (25.9)

 2

26 (32.1)

 3

3 (3.7)

 4

6 (7.4)

0.012

CD4 count category

 < 350

35 (61.4)

 > 350

22 (38.6)

0.404

Duration on ART

 0–5

59 (72.8)

 6–10

22 (27.2)

 > 10

0 (0)

0.486

Duration with HIV

 0–5

37 (58.7)

 6–10

18 (28.6)

 > 10

8 (12.7)

0.537

Duration with NCD

 0–5

36 (72)

 6–10

13 (26.0)

 > 10

1 (2.0)

0.004

Good adherence

 No

4 (4.94)

 Yes

77 (95.1)

0.204

Facility

 A

33 (40.7)

 B

48 (59.6)

0.004